An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York

Int J Environ Res Public Health. 2022 Nov 24;19(23):15629. doi: 10.3390/ijerph192315629.

Abstract

COVID-19 quickly spread across the United States (US) while communications and policies at all government levels suffered from inconsistency, misinformation, and lack of coordination. In order to explain the discrepancy between availability and population uptake, a case study was conducted analyzing vaccine rollout plans, social media, and Health Officer/Other Key Informant interviews in New Jersey, New York, and Pennsylvania. Key research questions included, "What were the barriers and facilitators of early COVID vaccine distribution?" and "What mechanisms in the community emerged to alleviate strains in early vaccination?" Findings from this study revealed that pre-existing emergency preparedness infrastructures and plans developed since the 9/11 tragedy were seemingly abandoned. This caused health departments at all levels of government to make impromptu, non-uniform decisions leading to confusion, vaccine hesitancy, and ultimately low uptake. The results indicate that future vaccine rollout best practices must include evidence-based decision-making, coordinated communications, and outreach to high-priority and vulnerable communities.

Keywords: pandemic; public health; vaccination; vaccine; vaccine distribution.

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • New Jersey / epidemiology
  • New York / epidemiology
  • Pennsylvania / epidemiology
  • Vaccination

Substances

  • COVID-19 Vaccines

Grants and funding

This research received no external funding.